MTOR and prostate neoplasm: Other significant pathways found to be upregulated in prostate tumors are the phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR), Ras/MAPK, DNA repair, and receptor tyrosine kinase pathways (143, 144).